DNA Biomed Solns (DNA) — Working Capital to Net Assets Ratio
DNA Biomed Solns (DNA) has a Working Capital to Net Assets ratio of 70.3% as of June 2025. Working capital of ILA69.02 Million (current assets of ILA70.47 Million minus current liabilities of ILA1.44 Million) is measured against net assets of ILA98.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See DNA Biomed Solns (DNA) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
DNA Biomed Solns Working Capital to Net Assets (2013–2024)
This chart shows how DNA Biomed Solns's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of June 2025, the ratio stands at 70.3%, reflecting working capital of ILA69.02 Million against net assets of ILA98.23 Million ILA. See DNA Biomed Solns defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for DNA Biomed Solns (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for DNA Biomed Solns from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of DNA Biomed Solns.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 66.3% | ILA67.30 Million | ILA101.47 Million | ILA68.43 Million | ILA1.13 Million | ▼ -17.3 pp |
| 2023 | 83.7% | ILA66.26 Million | ILA79.19 Million | ILA66.94 Million | ILA685.00K | ▲ +2.4 pp |
| 2022 | 81.3% | ILA65.14 Million | ILA80.11 Million | ILA65.93 Million | ILA789.00K | ▲ +37.8 pp |
| 2021 | 43.5% | ILA23.63 Million | ILA54.33 Million | ILA23.91 Million | ILA287.00K | ▲ +175.1 pp |
| 2020 | -131.6% | ILA-10.46 Million | ILA7.95 Million | ILA80.00K | ILA10.54 Million | ▼ -112.6 pp |
| 2019 | -19.0% | ILA-5.35 Million | ILA28.18 Million | ILA3.20 Million | ILA8.55 Million | ▲ +4.6 pp |
| 2018 | -23.6% | ILA-15.30 Million | ILA64.90 Million | ILA515.00K | ILA15.81 Million | ▼ -12.9 pp |
| 2017 | -10.7% | ILA-7.38 Million | ILA69.11 Million | ILA1.60 Million | ILA8.99 Million | ▼ -33.4 pp |
| 2016 | 22.7% | ILA-18.95 Million | ILA-83.41 Million | ILA21.93 Million | ILA40.88 Million | ▲ +105.1 pp |
| 2015 | -82.4% | ILA6.88 Million | ILA-8.35 Million | ILA11.44 Million | ILA4.56 Million | ▼ -91.7 pp |
| 2014 | 9.2% | ILA-773.00K | ILA-8.36 Million | ILA2.84 Million | ILA3.62 Million | ▼ -23.7 pp |
| 2013 | 32.9% | ILA3.78 Million | ILA11.49 Million | ILA6.64 Million | ILA2.86 Million | — |